Cerebral Infarction Clinical Trial
— LASTOfficial title:
Life After STroke - the LAST Study. A Norwegian Multi Centre Randomized Controlled Trial
NCT number | NCT01467206 |
Other study ID # | 205309/H10 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2011 |
Est. completion date | December 2015 |
Verified date | April 2020 |
Source | Norwegian University of Science and Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The LAST study is a Norwegian multi site randomised controlled trial that intends to assess the effect of a long term follow up program after stroke. The program consists of a coordinating physiotherapist who will encourage and motivate included patients to perform at least 60 minutes of intensive motor training every week and 30 minutes of physical activity every day for 18 months after inclusion. The primary hypothesis is that patients receiving a long term follow up program after stroke will have better motor function at end of follow up than patients receiving standard care. A total of 390 home dwelling stroke patients living in the municipality of Trondheim, Asker and Bærum will be included at the out-patient clinic at St. Olavs Hospital or Bærum Hospital three months after their stroke. Included patients will be randomised to an intervention group receiving the long term follow up program or to a control group receiving standard care. Motor function, mental health and physical functioning in daily life will be assessed at inclusion and 18 months later. The LAST study is funded by the Norwegian Research Council, the Norwegian University of Science and Technology and the Central Norway Regional Health Authority and will conclude at the end of 2015.
Status | Completed |
Enrollment | 380 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 95 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of stroke according to WHO's definition of stroke - Living in the city of Trondheim or the municipalities of Asker or Bærum - Included 2.5 - 4 months after stroke - Modified Rankin Scale 0 - 4 - Living at home - Mini Mental State Examination > 20 or > 16 if aphasia - Provide informed consent Exclusion Criteria: - Are already included in the study - Are included in other experimental studies - Unstable coronary function - Uncompensated heartfailure - Other diseases that make it difficult to complete the intervention |
Country | Name | City | State |
---|---|---|---|
Norway | Bærum Hospital | Sandvika | |
Norway | St. Olavs Hospital | Trondheim |
Lead Sponsor | Collaborator |
---|---|
Norwegian University of Science and Technology | Asker & Baerum Hospital, Helse Midt-Norge, St. Olavs Hospital, The Research Council of Norway |
Norway,
Askim T, Langhammer B, Ihle-Hansen H, Gunnes M, Lydersen S, Indredavik B; LAST Collaboration Group. Efficacy and Safety of Individualized Coaching After Stroke: the LAST Study (Life After Stroke): A Pragmatic Randomized Controlled Trial. Stroke. 2018 Feb; — View Citation
Askim T, Langhammer B, Ihle-Hansen H, Magnussen J, Engstad T, Indredavik B. A Long-Term Follow-Up Programme for Maintenance of Motor Function after Stroke: Protocol of the life after Stroke-The LAST Study. Stroke Res Treat. 2012;2012:392101. doi: 10.1155/2012/392101. Epub 2012 Nov 22. — View Citation
Døhl Ø, Halsteinli V, Askim T, Gunnes M, Ihle-Hansen H, Indredavik B, Langhammer B, Phan A, Magnussen J. Factors contributing to post-stroke health care utilization and costs, secondary results from the life after stroke (LAST) study. BMC Health Serv Res. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | VO2-peak | VO2-peak is obtained by use of a symptom limited treadmill test to measure cardiovascular fitness. This measure is only used in the Trondheim arm of the study |
18 months follow up | |
Primary | Motor Assessment Scale | A measure of over all motor function | 18 months after inclusion | |
Secondary | Barthel Index | A measure of activities of daily living | 18 months follow up | |
Secondary | Modified Rankin Scale | A measure of dependency/independency | 18 months follow up | |
Secondary | Berg Balance Scale | A measure of balance related to basic movement tasks | 18 months follow up | |
Secondary | Timed Up and Go | A measure of balance related to transfer and walking | 18 months follow up | |
Secondary | Sit to stand test | A measure of dynamic muscle strength according to a sit to stand task | 18 months follow up | |
Secondary | Six minute walk test | A measure of endurance | 18 months follow up | |
Secondary | Stroke Impact Scale | A measure of health related quality of life after stroke | 18 months follow up | |
Secondary | EuroQol 5D | A simple measure of health related quality of life for the general population | 18 months follow up | |
Secondary | Fatigue Severity Scale | A measure of the presence of fatigue | 18 months follow up | |
Secondary | One simple question on fatigue from the HUNT3 questionnaire | A simple question used to assess tiredness in teh general Norwegian population | 18 months follow up | |
Secondary | Hospital Anxiety and Depression Scale | A measure of anxiety and depression | 18 months follow up | |
Secondary | Mini Mental State Examination | A measure of cognitive function | 18 months follow up | |
Secondary | Montreal Cognitive Assessment | A measure of cognitive function related to vascular dementia | 18 months follow up | |
Secondary | falls | Serious falls will be recorded from the patients hospital records | 6, 12 and 18 months | |
Secondary | Readmission to hospital | Number of readmissions to hospital will be recorded from the patients medical records | 6, 12 and 18 months | |
Secondary | Death | Information about death will be collected from the Norwegain Death Registry | 6, 12 and 18 months | |
Secondary | Fractures | Information about fractures during follow up will be collected from the patients medical records | 6, 12 and 18 months | |
Secondary | Cardiovascular events | Information about any cardiovascular events will be collected from the patients medical record | 6, 12 and 18 months | |
Secondary | Cerebrovascular events | Information about any cerebrovascular events during follow up will be collected from teh patient's medical records | 6, 12 and 18 months | |
Secondary | International Physical Activity Questionnaire | A measure of physical activity over the last week | 6, 12 and 18 months | |
Secondary | Physical activity assessed by ActivPAL sensor system | A sensor system to assess the amount of physical activity during a 4-7 day period | 6, 12 and 18 months | |
Secondary | Three simple questions on physical activity from the HUNT questionnaire | A simple measure of physical activity | 18 months | |
Secondary | Health costs | Information about the use of health services will be collected by reviewing the patients' hospital records and records in primary health care system. | 6, 12 and 18 months | |
Secondary | National Institutes of Health Stroke Scale | A measure of stroke severity | 18 months follow up | |
Secondary | Modified Ashworth Scale | A measure to rate the degree of spasticity after stroke | 18 months follow up | |
Secondary | Gait speed | A simple measure of maximum gait speed across a 10 metres distance | 18 months follow up | |
Secondary | Trailmaking test A and B | A simple measure of executive cognitive function | 18 months follow up | |
Secondary | DS-14 | A standard assessment of negative affectivity, social inhibition, and type D personality, which might be related to poor cardiovascular prognosis. | 18 months follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02551003 -
Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
|
Phase 1/Phase 2 | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT00684515 -
Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)
|
Phase 2 | |
Not yet recruiting |
NCT04082091 -
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
|
||
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Terminated |
NCT01684462 -
The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
|
Phase 2 | |
Completed |
NCT00386191 -
Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
|
Phase 4 | |
Completed |
NCT00004734 -
Vitamin Therapy for Prevention of Stroke
|
Phase 3 | |
Completed |
NCT02684825 -
Detection of Silent Atrial Fibrillation aFter Ischemic StrOke
|
N/A | |
Completed |
NCT02248233 -
Nimodipine for Treating Acute Massive Cerebral Infarction
|
Phase 4 | |
Completed |
NCT02963545 -
TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke
|
N/A | |
Completed |
NCT02511249 -
Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke
|
N/A | |
Completed |
NCT02101606 -
Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
|
Phase 2 | |
Completed |
NCT01500421 -
Safty and Feasibility Study of Therapeutic Cooling in Acute Ischemic Stroke (COOLAID Øresund)
|
Phase 2 | |
Completed |
NCT00829361 -
Stroke Telemedicine for Arizona Rural Residents Trial
|
N/A | |
Recruiting |
NCT01003470 -
Treating Apoplectic Sequela With Acupuncture: a Randomized Controlled Study
|
Phase 2 | |
Terminated |
NCT00331890 -
ICTUS Study: International Citicoline Trial on Acute Stroke
|
Phase 3 | |
Not yet recruiting |
NCT04696523 -
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
|
Phase 2 | |
Completed |
NCT03741400 -
Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke
|
N/A |